The Prognosis Value of Lymphatic Vessel Invasion in pN0 Gastric Cancer Patients with Insufficient Examined Lymph Nodes.


Journal

Journal of gastrointestinal surgery : official journal of the Society for Surgery of the Alimentary Tract
ISSN: 1873-4626
Titre abrégé: J Gastrointest Surg
Pays: United States
ID NLM: 9706084

Informations de publication

Date de publication:
02 2020
Historique:
received: 05 08 2018
accepted: 29 12 2018
pubmed: 24 1 2019
medline: 2 3 2021
entrez: 24 1 2019
Statut: ppublish

Résumé

To investigate the prognosis value of lymphatic vessel invasion (LVI) in pN0 gastric cancer patients with insufficient examined lymph nodes (ELNs). Clinicopathologic and prognostic data of pN0 gastric cancer patients with insufficient ELNs who underwent radical surgery in our institution were retrospectively studied. Firstly, we confirmed that less than 16 but not less than 30 ELNs were insufficient ELNs in the present study. Of the 350 pN0 patients with < 16 ELNs, 64 patients (18.29%) had LVI. The overall survival (OS) of patients with LVI was significantly poorer than those without LVI. Multivariate analysis suggested that LVI was one of the independent factors predicting prognosis of pN0 patients with < 16 ELNs. Further analyses suggested that there were similar prognoses between pN0 patients with < 16 ELNs who had LVI and pN1 patients, and between pN0 patients with < 16 ELNs who had no LVI and pN0 patients with ≥ 16 ELNs, respectively. Therefore, we proposed a novel pN classification, in which LVI-positive pN0 gastric cancer with < 16 ELNs was classified as pN1 disease. Two-step multivariate analysis demonstrated that the novel pN classification was more suitable for prognostic assessment than the original one. LVI is a powerful and independent prognostic factor for pN0 gastric cancer patients with < 16 ELNs, and node-negative gastric cancer with < 16 ELNs which had LVI should be considered as node-positive disease. LVI is an effective indicator identifying patients stage migration happens to in pN0 patients with < 16 ELNs.

Identifiants

pubmed: 30671803
doi: 10.1007/s11605-018-04101-z
pii: 10.1007/s11605-018-04101-z
doi:

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

299-306

Références

Cancer. 2005 Feb 1;103(3):492-500
pubmed: 15612028
Virchows Arch. 2009 Feb;454(2):143-51
pubmed: 19104832
Ann N Y Acad Sci. 2008;1131:225-34
pubmed: 18519975
J Gastrointest Surg. 2011 Sep;15(9):1526-31
pubmed: 21717282
Ann Surg. 1998 Oct;228(4):449-61
pubmed: 9790335
Am Surg. 1998 Jul;64(7):680-5
pubmed: 9655282
Ann Surg Oncol. 2016 Jan;23(1):142-8
pubmed: 25986866
N Engl J Med. 1985 Jun 20;312(25):1604-8
pubmed: 4000199
Ann Oncol. 2009 May;20(5):897-905
pubmed: 19179553
BMC Cancer. 2014 Sep 18;14:676
pubmed: 25234410
Lancet. 2003 Jul 26;362(9380):305-15
pubmed: 12892963
Cancer. 2010 Jun 1;116(11):2571-80
pubmed: 20336791
J Surg Res. 2014 Dec;192(2):494-502
pubmed: 25033702
J Gastroenterol Hepatol. 2009 Sep;24(9):1527-33
pubmed: 19383080
Thorac Cardiovasc Surg. 2014 Sep;62(6):521-4
pubmed: 24905019
Clin Exp Metastasis. 2010 Mar;27(3):123-32
pubmed: 20195706
J Clin Oncol. 2005 Oct 1;23(28):7114-24
pubmed: 16192595
Cancer. 2012 Oct 1;118(19):4687-93
pubmed: 22415925
Am J Transl Res. 2015 Jan 15;7(1):120-7
pubmed: 25755834
Ann Surg Oncol. 2013 Nov;20(12):3927-34
pubmed: 23892524
Cancer. 1995 Jan 1;75(1):4-10
pubmed: 7804975
Br J Surg. 2001 Oct;88(10):1408-12
pubmed: 11578301

Auteurs

Jin-Yu Huang (JY)

Department of Surgical Oncology, First Affiliated Hospital of China Medical University, Shenyang, 110001, Liaoning, China.

Ya-Nan Xing (YN)

Department of Surgical Oncology, First Affiliated Hospital of China Medical University, Shenyang, 110001, Liaoning, China.

Xin Wang (X)

Department of Surgical Oncology, First Affiliated Hospital of China Medical University, Shenyang, 110001, Liaoning, China.

Zhen-Ning Wang (ZN)

Department of Surgical Oncology, First Affiliated Hospital of China Medical University, Shenyang, 110001, Liaoning, China.

Wen-Bin Hou (WB)

Department of Surgical Oncology, First Affiliated Hospital of China Medical University, Shenyang, 110001, Liaoning, China.

Song-Cheng Yin (SC)

Department of Surgical Oncology, First Affiliated Hospital of China Medical University, Shenyang, 110001, Liaoning, China.

Ying-Ying Xu (YY)

Department of Breast Surgery, First Affiliated Hospital of China Medical University, Shenyang, China.

Zhi Zhu (Z)

Department of Surgical Oncology, First Affiliated Hospital of China Medical University, Shenyang, 110001, Liaoning, China.

Hui-Mian Xu (HM)

Department of Surgical Oncology, First Affiliated Hospital of China Medical University, Shenyang, 110001, Liaoning, China. xuhuimian@126.com.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH